"25-Hydroxyvitamin D 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.
|25-Hydroxyvitamin D 2
- 25-Hydroxyvitamin D 2
- 25 Hydroxyvitamin D 2
- 25 Hydroxyergocalciferol
- 25-Hydroxyvitamin D2
- 25 Hydroxyvitamin D2
- 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol
- 25 Hydroxycalciferol
Below are MeSH descriptors whose meaning is more general than "25-Hydroxyvitamin D 2".
Below are MeSH descriptors whose meaning is more specific than "25-Hydroxyvitamin D 2".
This graph shows the total number of publications written about "25-Hydroxyvitamin D 2" by people in this website by year, and whether "25-Hydroxyvitamin D 2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "25-Hydroxyvitamin D 2" by people in Profiles.
Nikooyeh B, Shariatzadeh N, Rismanchi M, Hollis BW, Neyestani TR. Daily intake of yogurt drink fortified either with vitamin D alone or in combination with added calcium causes a thyroid-independent increase of resting metabolic rate in adults with type 2 diabetes: a randomized, double-blind, clinical trial. Appl Physiol Nutr Metab. 2021 Nov; 46(11):1363-1369.
Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013 Dec; 98(12):4619-28.
Binkley N, Drezner MK, Hollis BW. Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem. 2006 Nov; 52(11):2124-5.
Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem. 1993 Mar; 39(3):529-33.
Heubi JE, Hollis BW, Specker B, Tsang RC. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology. 1989 Feb; 9(2):258-64.
Anderson DM, Hollis BW, LeVine BR, Pittard WB. Dietary assessment of maternal vitamin D intake and correlation with maternal and neonatal serum vitamin D concentrations at delivery. J Perinatol. 1988; 8(1):46-8.
Sowers MR, Wallace RB, Hollis BW, Lemke JH. Parameters related to 25-OH-D levels in a population-based study of women. Am J Clin Nutr. 1986 Apr; 43(4):621-8.
Hollis BW, Frank NE. Quantitation of vitamin D2, vitamin D3, 25-hydroxyvitamin D2, and 25-hydroxyvitamin D3 in human milk. Methods Enzymol. 1986; 123:167-76.
Hollis BW, Pittard WB, Reinhardt TA. Relationships among vitamin D, 25-hydroxyvitamin D, and vitamin D-binding protein concentrations in the plasma and milk of human subjects. J Clin Endocrinol Metab. 1986 Jan; 62(1):41-4.
Specker BL, Tsang RC, Hollis BW. Effect of race and diet on human-milk vitamin D and 25-hydroxyvitamin D. Am J Dis Child. 1985 Nov; 139(11):1134-7.